Guggenheim Capital’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.3M Buy
48,151
+30,587
+174% +$8.12M 0.15% 129
2026
Q1
$1.93M Buy
17,564
+3,718
+27% +$530K 0.01% 716
2025
Q4
$2.3M Buy
13,846
+4,305
+45% +$720K 0.02% 639
2025
Q3
$1.87M Sell
9,541
-4,213
-31% -$693K 0.01% 693
2025
Q2
$1.24M Sell
13,754
-2,449
-15% -$193K 0.01% 807
2025
Q1
$967K Buy
16,203
+2,704
+20% +$250K 0.01% 889
2024
Q4
$1.79M Buy
+13,499
New +$1.27M 0.01% 692

Other funds holding ALAB

Guggenheim Capital's ALAB Position: Q2 2026 in Review

Guggenheim Capital increased its Astera Labs (ALAB) stake by 174% in Q2 2026, buying an estimated $8.12M and bringing the position to 48,151 shares worth $23.3M. The position accounts for 0.15% of the portfolio, ranked #129.

Guggenheim Capital first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Guggenheim Capital held 48,151 shares of Astera Labs worth $23.3M as of Q2 2026.
  • Guggenheim Capital bought 30,587 Astera Labs shares in Q2 2026, an estimated $8.12M.
  • Astera Labs made up 0.15% of Guggenheim Capital's portfolio in Q2 2026, its #129 holding.
  • Guggenheim Capital first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.